Some investigators have reported that mesothelin can be a new marker for the diagnosis of ovarian carcinoma (Huang et al, 2006; Yen et al, 2006) and as a target in mesothelin-expressing tumours (Fan et al, 2002; Hassan et al, 2007a, 2007b). This evidence concerns the gene MSLN and neoplasm.